MUSUMECI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 672
EU - Europa 422
AS - Asia 105
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.201
Nazione #
US - Stati Uniti d'America 672
GB - Regno Unito 139
IE - Irlanda 107
CN - Cina 87
SE - Svezia 51
UA - Ucraina 42
DE - Germania 24
IT - Italia 19
FR - Francia 17
FI - Finlandia 9
TR - Turchia 5
CZ - Repubblica Ceca 4
IN - India 4
IR - Iran 4
NL - Olanda 3
SG - Singapore 3
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
PL - Polonia 1
RO - Romania 1
Totale 1.201
Città #
Southend 127
Dublin 106
Fairfield 93
Ashburn 69
Chandler 62
Houston 53
Woodbridge 53
Menlo Park 44
Jacksonville 39
Seattle 38
Wilmington 32
Beijing 31
Cambridge 31
Ann Arbor 26
Nanjing 15
Princeton 15
Siena 15
New York 12
Dearborn 11
Shanghai 7
Boardman 6
Izmir 5
Nanchang 5
Tianjin 5
Düsseldorf 4
Fremont 4
San Diego 4
Washington 4
Hefei 3
Helsinki 3
Lancaster 3
Shenyang 3
Brno 2
Changsha 2
Edinburgh 2
Frankfurt am Main 2
Jiaxing 2
Jinan 2
Los Angeles 2
Moscow 2
Olomouc 2
San Mateo 2
Utrecht 2
Zanjan 2
Agliana 1
Bangalore 1
Berlin 1
Chengdu 1
Chiswick 1
Dubai 1
Guangzhou 1
Hebei 1
Kilburn 1
London 1
Málaga 1
Ningbo 1
Norwalk 1
Oklahoma City 1
Poggibonsi 1
San Francisco 1
Singapore 1
Sofia 1
Sucre 1
Taizhou 1
Tokyo 1
Venezia 1
Waltham 1
Warsaw 1
Xian 1
Totale 977
Nome #
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. 186
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 184
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 177
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 150
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 146
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 142
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivity 117
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies 114
Totale 1.216
Categoria #
all - tutte 3.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 38 12 16 39 18 32 30 36 20 24 11 13
2020/2021150 3 20 1 19 14 23 7 21 14 11 10 7
2021/2022114 5 25 3 3 6 0 9 2 5 12 18 26
2022/2023179 8 23 19 26 18 29 8 18 20 3 5 2
2023/2024172 4 4 13 5 7 52 61 11 0 7 2 6
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.216